The establishment of novel diagnostic and prognostic maker using epigenetic changes in upper tract urothelial carcinoma

The establishment of novel diagnostic and prognostic maker using epigenetic changes in upper tract urothelial carcinoma - Epigenetic changes in upper tract urothelial carcinoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005439

Enrollment

100

Registered

2011-05-01

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper tract urothelial carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. More than 20 years old at diagnosis. 2. Performance status (ECOG) of the cases should be 0 or 1. 3. Function of important organ should be sufficient. 4. Agreement form for this study should be obtained from the patients.

Exclusion criteria

Exclusion criteria: 1. Presence of active other cancers. 2. Having a severe complications occurred before this study; serious heart failure, renal failure, liver dysfunction, severe infection, and blood trouble

Design outcomes

Primary

Measure	Time frame
Cancer detection rate 3 and 5-year recurrence free rate 3 and 5-year cancer specific survival	—

Countries

Japan

Contacts

Public ContactEiji Kikuchi, Nobuyuki Tanaka

Keio University Hospital Department of Urology

urotanaka@a2.keio.jp03-3353-1211

Outcome results